Urinary markers in bladder cancer.
OBJECTIVE
Many markers for the detection of bladder cancers have been tested. Almost all urinary markers reported are better than cytology with regard to sensitivity, but they score lower in specificity. The purpose of this review is to highlight the most important urinary biomarkers studied and reported recently.


METHODS
Literature on bladder cancer markers has been reviewed regularly in the last few years. In the current review we have tried to summarise the most recent literature of urinary markers.


RESULTS
The results of this review show that the first-generation urinary markers did not add much to urinary cytology. The current generation of markers is promising but larger clinical trails are needed. The future of marker development is bright with new techniques emerging, but the perfect marker is still to be found.


CONCLUSIONS
Currently, no single marker can yet guide us in surveillance and lower the frequency of urethrocystoscopy.
Vrooman
Olaf P J
OP
Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Witjes
J Alfred
JA
D014408:Biomarkers, Tumor / Q000652:urine*; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D012720:Severity of Illness Index; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000652:urine*
D014408:Biomarkers, Tumor